| # | Thr. | #G | #C | GO BP | GO CC | GO MF | KEGG | miRNA | CHR |
| 59 | 4/1.4 | 30 | 13 | positive regulation of locomotion (0.00342/3.9e-02/ 3/ 12) | extracellular region (5.2e-05/1.3e+00/ 10/ 445) | cytokine activity (0.04042/ 0.0998/ 3/ 34) | |||
| 68 | 4/1.2 | 27 | 16 | response to external stimulus (0.00917/6.5e-01/ 6/ 252) | extracellular space (1.7e-04/3.3e-01/ 6/ 138) | cytokine activity (0.02367/ 0.0776/ 3/ 34) | |||
| 158 | 3.8/1.4 | 14 | 10 | ||||||
| 215 | 3.6/1.8 | 18 | 5 | proteinaceous extracellular matrix (1.1e-02/2.4e-01/ 4/ 108) | |||||
| 247 | 3.6/1.6 | 14 | 7 | collagen fibril organization (0.04797/2.6e-02/ 2/ 15) | fibrillar collagen (1.3e-02/1.5e-02/ 2/ 8) | ||||
| 257 | 3.6/1.4 | 51 | 14 | multicellular organismal process (0.00024/7.3e+00/ 22/1167) | extracellular region part (4.8e-05/1.4e+00/ 11/ 237) | cytokine activity (0.00015/ 0.1996/ 6/ 34) | Cytokine-cytokine receptor interaction (0.0091/0.5368/ 6/67) | ||
| 327 | 3.4/1.8 | 13 | 6 | ||||||
| 334 | 3.4/1.8 | 12 | 7 | ||||||
| 344 | 3.4/1.8 | 24 | 5 | extracellular region (4.7e-03/1.4e+00/ 8/ 445) | |||||
| 349 | 3.4/1.6 | 75 | 10 | organ morphogenesis (0.00013/2.2e+00/ 14/ 224) | extracellular region (8.2e-06/4.1e+00/ 19/ 445) | cytokine activity (0.00013/ 0.3049/ 7/ 34) | Cytokine-cytokine receptor interaction (0.0091/0.8525/ 7/67) | ||
| 434 | 3.2/2 | 27 | 6 | ||||||
| 439 | 3.2/2 | 27 | 4 | regulation of protein kinase activity (0.03843/1.3e-01/ 3/ 128) | |||||
| 452 | 3.2/1.8 | 42 | 4 | cytosolic ribosome (1.8e-02/2.7e-01/ 4/ 66) | |||||
| 457 | 3.2/1.8 | 45 | 6 | extracellular region part (1.2e-02/1.1e+00/ 7/ 237) | MAP kinase tyrosine/serine/threonine phosphatase activity (0.04042/ 0.0183/ 2/ 4) | ||||
| 504 | 3.2/1.4 | 37 | 6 | ||||||
| 544 | 3/2 | 52 | 3 | ||||||
| 548 | 3/2 | 61 | 5 | plasma membrane (4.6e-02/5.1e+00/ 13/ 988) | |||||
| 551 | 3/2 | 71 | 6 | ||||||
| 562 | 3/2 | 70 | 4 | multicellular organismal development (0.01784/7.7e+00/ 19/ 942) | extracellular region (2.8e-06/3.8e+00/ 19/ 445) | ||||
| 573 | 3/1.8 | 54 | 6 | plasma membrane part (2.7e-02/1.5e+00/ 7/ 568) | |||||
| 583 | 3/1.8 | 46 | 7 | ||||||
| 584 | 3/1.8 | 62 | 5 | ||||||
| 597 | 3/1.6 | 54 | 10 | monovalent inorganic cation transport (0.00386/4.9e-01/ 6/ 84) | |||||
| 626 | 3/1.2 | 53 | 8 | ||||||
| 640 | 3/1 | 42 | 14 | ||||||
| 645 | 2.8/2 | 125 | 6 | DNA binding (0.04042/ 9.1828/21/ 971) | |||||
| 654 | 2.8/2 | 103 | 6 | extracellular space (3.5e-02/1.4e+00/ 7/ 138) | |||||
| 665 | 2.8/2 | 93 | 5 | extracellular region part (1.0e-02/2.2e+00/ 10/ 237) | |||||
| 673 | 2.8/2 | 145 | 3 | JNK cascade (0.00083/1.8e-01/ 5/ 34) | |||||
| 692 | 2.8/1.8 | 82 | 5 | plasma membrane part (1.4e-02/2.5e+00/ 10/ 568) | receptor signaling protein activity (0.00921/ 0.3300/ 5/ 88) | ||||
| 693 | 2.8/1.8 | 104 | 5 | plasma membrane part (1.1e-02/2.5e+00/ 10/ 568) | receptor signaling protein activity (0.00921/ 0.3300/ 5/ 88) | ||||
| 716 | 2.8/1.4 | 93 | 12 | ||||||
| 743 | 2.6/2 | 195 | 6 | transcription (0.01434/1.6e+01/ 32/1170) | DNA binding (0.01225/14.0908/30/ 971) | ||||
| 747 | 2.6/2 | 151 | 3 | inflammatory response (0.00062/1.3e+00/ 10/ 98) | extracellular region part (2.1e-03/3.1e+00/ 13/ 237) | chemokine activity (0.04042/ 0.1044/ 3/ 8) | |||
| 751 | 2.6/2 | 186 | 7 | response to wounding (0.00054/2.7e+00/ 14/ 156) | extracellular region (5.2e-05/7.7e+00/ 25/ 445) | calcium ion binding (0.01295/ 4.8965/16/ 286) | |||
| 753 | 2.6/2 | 121 | 5 | MAPKKK cascade (0.00438/5.0e-01/ 6/ 81) | plasma membrane part (1.3e-02/4.0e+00/ 13/ 568) | receptor signaling protein activity (0.00030/ 0.5883/ 8/ 88) | MAPK signaling pathway (0.0274/1.2300/ 7/145) | ||
| 755 | 2.6/2 | 153 | 3 | ||||||
| 776 | 2.6/1.8 | 139 | 6 | activation of transmembrane receptor protein tyrosine kinase activity (0.03365/2.6e-02/ 2/ 2) | extracellular region (2.5e-06/6.3e+00/ 25/ 445) | ||||
| 781 | 2.6/1.8 | 139 | 5 | cytokine-mediated signaling pathway (0.04755/3.2e-01/ 4/ 25) | extracellular region (3.2e-03/5.9e+00/ 18/ 445) | ||||
| 782 | 2.6/1.8 | 132 | 8 | extracellular region (1.3e-05/6.1e+00/ 23/ 445) | extracellular matrix structural constituent (0.01298/ 0.3652/ 5/ 28) | ||||
| 792 | 2.6/1.6 | 130 | 8 | extracellular region (2.1e-02/5.3e+00/ 15/ 445) | endopeptidase activity (0.04042/ 1.5079/ 8/ 136) | ||||
| 805 | 2.6/1.6 | 185 | 6 | multicellular organismal process (0.01196/2.0e+01/ 38/1167) | extracellular region part (4.8e-05/4.0e+00/ 18/ 237) | ||||
| 808 | 2.6/1.4 | 127 | 8 | activation of transmembrane receptor protein tyrosine kinase activity (0.02798/2.3e-02/ 2/ 2) | proteinaceous extracellular matrix (7.1e-03/1.3e+00/ 8/ 108) | ||||
| 837 | 2.4/2 | 280 | 4 | transcription (0.00051/2.7e+01/ 52/1170) | nucleus (3.2e-02/6.0e+01/ 81/2586) | DNA binding (0.00044/23.1153/48/ 971) | miR-138 (0.038/ 6.040/18/210) | ||
| 838 | 2.4/2 | 193 | 4 | proteinaceous extracellular matrix (1.8e-03/2.1e+00/ 11/ 108) | |||||
| 840 | 2.4/2 | 218 | 5 | extracellular region (1.9e-02/8.8e+00/ 21/ 445) | |||||
| 855 | 2.4/2 | 193 | 4 | integral to plasma membrane (1.6e-02/4.5e+00/ 14/ 329) | receptor signaling protein activity (0.04580/ 1.1766/ 7/ 88) | ||||
| 863 | 2.4/1.8 | 201 | 7 | extracellular region (1.3e-06/9.9e+00/ 33/ 445) | |||||
| 866 | 2.4/1.8 | 121 | 6 | positive regulation of transforming growth factor beta receptor signaling pathway (0.02269/9.7e-02/ 3/ 8) | extracellular region part (1.9e-02/3.0e+00/ 11/ 237) | ||||
| 877 | 2.4/1.6 | 183 | 7 | proteinaceous extracellular matrix (6.4e-03/2.1e+00/ 10/ 108) | |||||
| 883 | 2.4/1.6 | 236 | 8 | transcription (0.00176/1.8e+01/ 37/1170) | DNA binding (0.00472/14.5658/32/ 971) | ||||
| 918 | 2.4/1.2 | 176 | 11 | extracellular region (1.6e-02/8.7e+00/ 21/ 445) | |||||
| 927 | 2.2/2 | 336 | 6 | extracellular region (2.4e-02/1.4e+01/ 28/ 445) | |||||
| 928 | 2.2/2 | 299 | 4 | extracellular region (4.7e-03/1.5e+01/ 32/ 445) | |||||
| 938 | 2.2/2 | 304 | 4 | plasma membrane part (1.1e-02/1.2e+01/ 27/ 568) | |||||
| 942 | 2.2/2 | 350 | 3 | ||||||
| 957 | 2.2/1.8 | 323 | 6 | extracellular region (1.3e-05/1.6e+01/ 41/ 445) | |||||
| 958 | 2.2/1.8 | 294 | 7 | extracellular region (2.9e-07/1.5e+01/ 44/ 445) | |||||
| 960 | 2.2/1.8 | 294 | 5 | plasma membrane part (2.7e-03/1.1e+01/ 26/ 568) | |||||
| 962 | 2.2/1.8 | 287 | 6 | plasma membrane part (2.4e-02/1.1e+01/ 24/ 568) | |||||
| 965 | 2.2/1.8 | 338 | 4 | lysosomal transport (0.04784/3.5e-01/ 4/ 12) | |||||
| 968 | 2.2/1.8 | 334 | 5 | ||||||
| 996 | 2.2/1.4 | 184 | 9 | cell junction (2.4e-02/3.0e+00/ 11/ 154) | |||||
| 1007 | 2.2/1 | 303 | 21 | regulation of cellular process (0.00133/7.5e+01/105/2692) | transcription factor activity (0.00044/10.6108/30/ 374) | miR-101 (0.030/13.008/30/355) | |||
| 1011 | 2/2 | 446 | 4 | extracellular region (4.1e-06/2.3e+01/ 53/ 445) | |||||
| 1012 | 2/2 | 546 | 4 | regulation of transcription (0.00012/5.1e+01/ 90/1084) | DNA binding (0.00013/47.4971/85/ 971) | miR-200bc/429 (0.030/29.828/54/493) | |||
| 1032 | 2/2 | 486 | 5 | extracellular region (4.9e-03/1.9e+01/ 38/ 445) | |||||
| 1037 | 2/2 | 343 | 5 | antigen processing and presentation of peptide antigen via MHC class I (0.00181/4.4e-01/ 6/ 15) | MHC class I protein complex (4.5e-04/4.2e-01/ 6/ 13) | MHC class I receptor activity (0.00141/ 0.2361/ 5/ 8) | Type I diabetes mellitus (0.0062/0.4411/ 6/13) | ||
| 1049 | 2/1.8 | 459 | 7 | extracellular region (1.3e-05/2.4e+01/ 53/ 445) | |||||
| 1083 | 2/1.4 | 423 | 11 | extracellular region (1.1e-06/2.2e+01/ 54/ 445) | extracellular matrix structural constituent (0.01640/ 1.3422/ 8/ 28) | Autoimmune thyroid disease (0.0251/0.5287/ 5/11) | |||
| 1087 | 2/1.2 | 399 | 13 | regulation of cellular process (0.00056/1.0e+02/137/2692) | extracellular space (2.4e-02/5.2e+00/ 15/ 138) | transcription factor activity (0.00125/13.9648/34/ 374) | Cytokine-cytokine receptor interaction (0.0127/2.5259/11/67) | miR-17-5p/20/93.mr/106/519.d (0.030/25.377/47/539) | |
| 1090 | 2/1 | 464 | 20 | transcription (0.00013/4.0e+01/ 73/1170) | DNA binding (0.00015/35.1479/67/ 971) |
